LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
AVLNCIK 0001540171

Avalyn Pharma Inc.

45 transactions by 15 insiders, from April 29, 2026 to September 15, 2026.

Transactions
4515 insiders
Bought · P
$25.0Mopen market
Sold · S
Nonenobody sold on the open market
Net
+$25.0Mnet buying

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
Jill CarrollDir5—$5.0M—
Erin LavelleDir1———
Lyn BaranowskiCEO1———
Melissa RhodesCOO1———
Howard LazarusCMO1———
Adam H. GoldenGC1———
Heather D. TurnerDir1———
Douglas R. CarlsonCFO1———
Jon CongletonDir1———
Kate HavilandDir1———

Large holders and funds

Holders above 10%, often funds. They file the same form, but they trade for portfolio reasons, not because of what they know.

InsiderTradesPlannedBoughtSold
SR ONE CAPITAL MANAGEMENT, LLC10%10—$10.0M—
FMR LLC10%10———
Novo Holdings A/S10%7—$10.0M—
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.10%3———

Role not yet known

These filings have not been read with the current parser yet, so we do not know in what capacity they signed.

InsiderTradesPlannedBoughtSold
Robert J. Meyer1———

All transactions

45 in total, newest filings first.

InsiderDateCodeSharesPriceValue
Robert J. MeyerDERIVSep 15A31,182$0.00—?
Novo Holdings A/S10%DERIVMay 1C12,558,081$0.00—?
Novo Holdings A/S10%DERIVMay 1C5,587,603$0.00—?
Novo Holdings A/S10%DERIVMay 1C25,899,284$0.00—?
Novo Holdings A/S10%DERIVMay 1C1,986,369$0.00—?
Novo Holdings A/S10%DERIVMay 1C18,000,000$0.00—?
Novo Holdings A/S10%May 1P555,555$18.00$10.0M
Novo Holdings A/S10%May 1C3,327,734——
FMR LLC10%DERIVMay 1C377,948——
FMR LLC10%DERIVMay 1C225,843——
FMR LLC10%DERIVMay 1C872,868——
FMR LLC10%DERIVMay 1C80,291——
FMR LLC10%DERIVMay 1C727,585——
FMR LLC10%May 1C377,948——
FMR LLC10%May 1C225,843——
FMR LLC10%May 1C872,868——
FMR LLC10%May 1C80,291——
FMR LLC10%May 1C727,585——
Adam H. GoldenGCDERIVApr 29A254,891$0.00—?
Jill CarrollDirDERIVMay 1C9,418,561——
Jill CarrollDirDERIVMay 1C27,309,719——
Jill CarrollDirMay 1P277,778$18.00$5.0M
Jill CarrollDirMay 1C489,486——
Jill CarrollDirMay 1C1,419,298——
SR ONE CAPITAL MANAGEMENT, LLC10%DERIVJOINTMay 1C9,418,560——
SR ONE CAPITAL MANAGEMENT, LLC10%DERIVJOINTMay 1C6,827,429——
SR ONE CAPITAL MANAGEMENT, LLC10%DERIVJOINTMay 1C9,418,561——
SR ONE CAPITAL MANAGEMENT, LLC10%DERIVJOINTMay 1C27,309,719——
SR ONE CAPITAL MANAGEMENT, LLC10%JOINTMay 1P277,777$18.00$5.0M
SR ONE CAPITAL MANAGEMENT, LLC10%JOINTMay 1C489,486——
SR ONE CAPITAL MANAGEMENT, LLC10%JOINTMay 1C354,824——
SR ONE CAPITAL MANAGEMENT, LLC10%JOINTMay 1P277,778$18.00$5.0M
SR ONE CAPITAL MANAGEMENT, LLC10%JOINTMay 1C489,486——
SR ONE CAPITAL MANAGEMENT, LLC10%JOINTMay 1C1,419,298——
Jon CongletonDirDERIVApr 29A26,978$0.00—?
Heather D. TurnerDirDERIVApr 29A26,978$0.00—?
Melissa RhodesCOODERIVApr 29A211,975$0.00—?
Douglas R. CarlsonCFODERIVApr 30A211,975$0.00—?
Kate HavilandDirDERIVApr 29A26,978$0.00—?
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.10%DERIVMay 1C4,060,259$0.00—?
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.10%DERIVMay 1C20,482,289$0.00—?
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.10%May 1C1,275,486——
Howard LazarusCMODERIVApr 29A211,975$0.00—?
Erin LavelleDirDERIVApr 30A26,978$0.00—?
Lyn BaranowskiCEODERIVApr 29A501,033$0.00—?